UnitedHealth Group (UNH), a diversified healthcare company, has been named as a possible suitor in the sale of Tenet Healthcare’s (THC) Conifer unit. If a deal takes place between the two firms, analysts expect Tenet to value its wholly owned operating subsidiary, Conifer Health Solutions to about $2 billion.
In 2017, Tenet — under the pressure of its largest shareholder Glenview Capital Management — put its healthcare management subsidiary Conifer up for sale. In 2017, Confier accounted for 8% of the total sales. The sale of Conifer is a part of the company’s larger plan of restructuring that includes cutting workforce, divesting hospitals, breaking business segments and cut cost by $100 million by the end of this year.
According to the latest reports by the Wall Street Journal, the insurance giant is one of the companies that is aiming to acquire Tenet’s Conifer unit. There are no details on the other potential suitors. However, there is no certainty that the deal between UnitedHealth and Tenet will be consummated. If it does, Conifer would be a part of UnitedHealth’s fastest growing business Optum.
Related: UnitedHealth Group reports Q2 earnings above estimates
This week, UnitedHealth Group reported its Q2 earnings that topped analyst estimates. It posted a 12% growth in its revenues to $56.1 billion, generating profits of $2.98 per share. Adjusted EPS totaled $3.14 for the quarter. Both GAAP and adjusted EPS grew 28% year-over-year. Despite the strong results, the company’s stock is trading in the red. As of today, the company’s share price is down 0.95% to $252.96.
UnitedHealth Group Q2 Infographic
Most Popular
V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results
Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew
Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results
Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter
McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings
Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings